Palvella Therapeutics (NASDAQ:PVLA) Price Target Raised to $250.00 at Mizuho
Palvella Therapeutics (NASDAQ:PVLA – Get Free Report) had its price objective increased by research analysts at Mizuho from $205.00 to $250.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Mizuho’s target price suggests a potential upside of 102.74% from the stock’s previous close. A number of [...]